|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.00 INR | +0.53% |
|
+0.53% | -9.74% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 |
|---|---|
| Market Cap 1 | 91.84 |
| Change | - |
| Enterprise Value (EV) 1 | 61.1 |
| Change | - |
| P/E Ratio | 21.2x |
| PBR | 1.04x |
| PEG | -1.1x |
| Capitalization / Revenue | 1.12x |
| EV / Revenue | 0.74x |
| EV / EBITDA | 7.09x |
| EV / EBIT | 14.8x |
| EV / FCF | - |
| FCF Yield | - |
| Dividend per Share 2 | - |
| Rate of return | - |
| EPS 2 | 1.896 |
| Distribution rate | - |
| Net sales 1 | 82.35 |
| EBITDA 1 | 8.62 |
| EBIT 1 | 4.122 |
| Net income 1 | 3.947 |
| Net Debt 1 | -30.75 |
| Reference price 2 | 40.24 |
| Nbr of stocks (in thousands) | 2,282 |
| Announcement Date | 8/26/25 A |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 912K | ||
| -128.03x | 10.49x | -145.14x | -.--% | 30.37B | ||
| 18.49x | 1.79x | 10.36x | 1.09% | 21.83B | ||
| 16.51x | 1.29x | 7.29x | 5.33% | 7.04B | ||
| 290.82x | - | - | - | 4.46B | ||
| 52.79x | 9.32x | 32.7x | 0.87% | 2.82B | ||
| 31.04x | 1.25x | 10.31x | 0.81% | 1.79B | ||
| -19.99x | - | - | - | 1.78B | ||
| 34.63x | 1.52x | 12.38x | 1.55% | 1.73B | ||
| 11.94x | 1.26x | 4.94x | 6.34% | 1.63B | ||
| Average | 34.24x | 3.85x | -9.59x | 2.29% | 7.34B | |
| Weighted average by Cap. | -24.84x | 5.95x | -59.39x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
















